This page lists all the CE Podcasts that are available from ASHP Advantage. To subscribe to ASHP Advantage Podcasts, and automatically receive new programs when they are published, copy the URL from the box below and paste it into your favorite podcasting tool (e.g., iTunes, iPodder). The program materials (e.g., slides, CE instructions, and post test) are also available via this page.
How to Subscribe?
Click on the icon below to subscribe directly using your preferred podcasting tool:
Or, copy and paste this URL into a podcasting tool.
After trying our Podcast Program, please complete the short survey so we can improve future podcasts. Click here to take survey
Learn More About Podcasts and using them to obtain CE.
The CE Podcasts are recordings of programs that were originally presented in a live setting. The advantage of the podcast format is that you automatically receive the audio from the program in a format that can be listened to from your computer and transferred to a portable MP3 player. You do not need an iPod or MP3 player to take advantage of podcast convenience, audio files can be played on any computer with the ability to play audio files (i.e., Windows Media Player or other software).
Summary: The therapeutic necessity for blood transfusions is well established; however, the transfusion of human plasma-derived components is not without drawbacks. There is significant expense associated with the testing, storage, and transfusion of blood products. Blood transfusions also pose a number of safety risks. The challenges and clinical shortcomings of blood transfusions have led clinicians to seek strategies to reduce blood transfusions. Those strategies include anemia management, blood conservation, the use of hemostatic agents and therapeutic alternatives to blood transfusion, and the development of hospital-specific transfusion guidelines. There are many examples in the medical literature documenting improvements in patient care and health care resource utilization associated with the systematic development and institution-wide implementation of evidence-based, interdisciplinary treatment guidelines and protocols. These issues and other important topics in transfusion medicine will be addressed in this program.
Part 1 Transfusion Strategies for Critically Bleeding Patients: Clinical
Overview & Current Concepts of Blood Product Administration
Ira A. Shulman, M.D.
Part 2 Therapeutic Adjuncts for Treatment of Critically Bleeding Patients
Jill A. Rebuck, Pharm.D., BCPS, FCCM
Part 3 What's the Evidence? Rationale and Outcomes of Successful Transfusion
Protocols
Joseph Dasta, M.Sc.
Continuing Education The program was originally presented at the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas in December 2007. Continuing education for this podcast is available until February 28, 2009. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. 204-000-07-462-H01P
Credits: A maximum of 2 hours (0.25 CEUs) Expected Duration: 2 hours
Summary: This program provides an overview of the prevalence, pathogenesis, and diagnosis of ADHF. Factors used to stratify patients with ADHF according to risk for unfavorable outcomes will be reviewed. The program also outlines current evidence based ADHF treatment guidelines and reviews the findings of recent clinical studies on new drug therapies for ADHF. Real-life case studies are used to illustrate the therapeutic decision-making process.
Part 1 Acute Decompensated Heart Failure: Overview of Prevalence, Pathogenesis, Diagnosis, and Prognosis
Tien M.H. Ng, Pharm.D., BCPS
Part 2 Current Acute Decompensated Heart Failure Treatment Guidelines and Recent Clinical Research Findings
Jo E. Rodgers, Pharm.D., BCPS (AQ Cardiology)
Part 3 Incorporating Treatment Guidelines and Recent Clinical Research Findings into Practice in the Institutional Setting: Case Studies in ADHF
Michael A. Crouch, Pharm.D., BCPS (AQ Cardiology)
Part 4 Future Directions in the Management of ADHF
Tien M.H. Ng, Pharm.D., BCPS
Continuing Education The program was originally presented at the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas in December 2007. Continuing education for this podcast is available until February 28, 2009. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. 204-000-07-472-H01P
Summary: This program provides an overview of the prevalence, morbidity, and mortality in adults associated with herpes zoster, influenza, meningococcal disease, pertussis, and HPV infection. Recent changes to the ACIP recommendations for immunization and information about the efficacy, safety, and administration of new immunization products also will be discussed. The
status of research efforts to develop immunization products with a large potential public health benefit will be briefly described. Finally, the role of the health-system pharmacist as an advisor on immunizations in preventing disease will be addressed.
FACULTY: Michael E. Klepser, Pharm.D., FCCP
Continuing Education The program was originally presented at the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas in December 2007. Continuing education for this podcast is available until February 28, 2009. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. Program number 204-000-07-468-H01P.
Credits: Maximum of 1 hour (0.1 CEUs) Expected Duration: 1 hour
Summary
This program will describe the relationships between inappropriate antimicrobial use, antimicrobial resistance, and increased morbidity, mortality, and hospital length of stay. Pharmacy expenditures and factors affecting reimbursement will be addressed. The potential impact of antimicrobial stewardship programs on the emergence and transmission of antimicrobial-resistant microorganisms also will be discussed. Challenges associated with antimicrobial stewardship program implementation and examples of successful multidisciplinary team approaches to antimicrobial stewardship will be provided.
FACULTY: Debra A. Goff, Pharm.D., FCCP
Continuing Education The program was originally presented at the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas in December 2007. Continuing education for this podcast is available until February 28, 2009. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. Program number 204-000-07-469-H01P
Summary
This program discusses trends in the prevalence of type 2 diabetes and strategies to achieve goals for glycemic control. The role of incretins in postprandial glycemic control in healthy persons and the incretin abnormalities that contribute to type 2 diabetes will be explained. The mechanisms of action, routes of administration, efficacy, and safety of currently available and investigational incretin analogs and DPP-4 enzyme inhibitors in patients with type 2 diabetes will be described. The role of incretin analogs and DPP-4
inhibitors in managing type 2 diabetes will be illustrated through a patient case study.
Part 1: The Burden of Uncontrolled Type 2 Diabetes
John T. Johnson, Pharm.D., CDE
Part 2: A New Target in the Treatment of Type 2 Diabetes: The Incretin Effect
Susan Cornell, B.S., Pharm.D., CDE, CDM
Continuing Education The program was originally presented at the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas in December 2007. Continuing education for this podcast is available until February 28, 2009. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. Program number 204-000-07-466-H01P
Summary
This program will provide a brief review of the relationship between dyslipidemia, the metabolic syndrome, and CHD and current NCEP guidelines for treating dyslipidemia. The importance of HDL cholesterol in determining CHD risk and the impact of raising levels on risk for CHD will be described. The role of statins, niacin, fibrates, and other agents in the treatment of dyslipidemia, including effects of the drugs on patients with mixed dyslipidemia, type 2 diabetes, and the metabolic syndrome, also will be presented. Persistent
myths and unresolved controversies in dyslipidemia management that are not addressed in the NCEP guidelines will be discussed.
Part 1: HDL Cholesterol as a Therapeutic Target in Patients with Dyslipidemia
Matthew K. Ito, Pharm.D., FCCP, BCPS, CLS
Part 2: Challenges in Managing Dyslipidemia in Patients with Mixed Dyslipidemia, Type 2 Diabetes, or the Metabolic Syndrome
Joseph J. Saseen, Pharm.D., FCCP, BCPS, CLS
Continuing Education The program was originally presented at the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas in December 2007. Continuing education for this podcast is available until February 28, 2009. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. Program number 204-000-07-467-H01P
Summary: This educational activity for pharmacists provides an overview of the multimodal approach for managing postoperative ileus, including its multifactorial etiology and impact on patient and economic outcomes. Current treatment options for postoperative ileus will be presented, focusing on the role of health-system pharmacists in the multidisciplinary care of perioperative patients. The results of current clinical research exploring new and emerging pharmacologic options for preventing and managing postoperative ileus also will be presented.
Part 1 Postoperative Ileus: A Multifaceted Health Problem
Brian L. Erstad, Pharm.D., FCCM, FASHP, FCCP, BCPS, Program Chair
Part 2 Managing Postoperative Ileus
Robert MacLaren, Pharm.D., FCCM, FCCP
Part 3 New and Emerging Options for Managing Postoperative Ileus: Clinical Research and Potential Implications for Pharmacists
Michael D. Kraft, Pharm.D.
Continuing Education The program was originally presented at the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas in December 2007. Continuing education for this podcast is available until February 28, 2009. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. Program number 204-000-07-451-H01P
Summary: This program will provide an overview of COPD, including a description of the natural course of disease progression. The program will describe current pharmacological approaches as well as the importance of the health care team in managing the disease across the continuum of care. The role of the health care team in teaching patients about COPD, available devices, and self-management will be discussed. Patient cases and audience response system technology was used during the interactive live session to illustrate strategies for long-term management of COPD. The results are included in the podcast. There are two parts to this activity.
Part 1 Changing Perspective in the Natural History of COPD
James F. Donohue, M.D.
Role of Long-acting Bronchodilators in the Management of COPD
James F. Donohue, M.D.
Part 2 Benefits and Risks of Anti-inflammatory and Immunologic Therapies in COPD
Management
Dennis M. Williams, Pharm.D., BCPS, AE-C
Considerations in the Selection and Appropriate Use of Inhalation Delivery
Systems
Dennis M. Williams, Pharm.D., BCPS, AE-C
Continuing Education The program was originally presented as an Exhibitor Theater at the
42nd ASHP Midyear Clinical Meeting and Exhibition, in Las Vegas, Nevada. Continuing education for this podcast is available from March 1, 2008, until February 28, 2009. To be eligible for continuing medical education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center.
Summary: This educational activity for physicians provides an update on the therapeutic management of postoperative ileus (POI). The pathophysiology of POI will be reviewed, and particular emphasis will be placed on the impact of surgery type, anesthesia, and analgesia, and other components of enhanced-recovery protocols on POI will be presented. Current clinical research exploring potential new therapies for preventing and minimizing the effect of POI will be described. There are three parts to this activity.
Part 1 Enhanced Recovery Surgery: State of the Art
Anthony Senagore, M.D., M.S., M.B.A., FACS, FASCRS
Part 2 Impact of Anesthesia and Analgesia on Postoperative Ileus: A View from "Above the Screen"
T.J. Gan, M.B., B.S., FRCA
Part 3 Emerging Pharmacologic Options for Managing Postoperative Ileus
Conor P. Delaney, M.D., M.Ch., Ph.D., FRCSI, FACS
Continuing Education The program was originally presented in New Orleans on October 7, 2007. Continuing education for this podcast is available until January 27, 2009. To be eligible for continuing medical education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center.
Credits: Maximum of 2.0 AMA PRA Category 1 CreditsTM. Expected Duration: 2 hours
This activity is sponsored by the American Society of Health-System Pharmacists and was planned by ASHP Advantage, a division of ASHP. It is supported by an educational grant from Adolor Corporation and GlaxoSmithKline.
Eleventh Annual ASHP Conference for Leaders in Health-System Pharmacy
Summary: This podcast is based on a program that was originally presented live as part of the 2006 ASHP Conference for Leaders, which was held in Chicago, Illinois, October 16-17, 2006. The theme of the conference was "Developing High Performing Staff and Services."
The presentation was written and presented by Kasey K. Thompson, Pharm.D., who is the Director, Practice Standards and Quality Division and Director, Patient Safety at the American Society of Health-System Pharmacists in Bethesda, Maryland. It was repurposed as a podcast by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers.
This podcast was produced by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers.
C.E. Credits: Not available for this program. Duration: 39 minutes
This podcast was produced by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers. The ASHP Conference for Leaders was made possible by the support of Amgen, Eli Lilly, Roche Pharmaceuticals, and Wyeth.
Tenth Annual ASHP Conference for Leaders in Health-System Pharmacy
Summary: This podcast is based on a program that was originally presented live as part of the Tenth Annual ASHP Conference for Leaders in Health-System Pharmacy. The conference was held October 17 and 18, 2005. The theme of the conference was "Balancing Competing Demands: Practical Strategies for Pharmacy Leaders."
The live program was written and presented by Anne T. Jarrett, Assistant Director of Pharmacy at Wake Forest University Baptist Medical Center in Winston-Salem, North Carolina; Rose Marie Babbitt, Associate Director of Pharmacy at Parkland Health and Hospital Systems in Dallas, Texas; and Rita R. Shane, Director of Pharmacy Services at Cedars-Sinai Medical Center in
Los Angeles, California.
This podcast was produced by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers.
C.E. Credits: Not available for this program. Duration: 14 minutes
Summary: This podcast is based on a program that was originally presented live as part of the Tenth Annual ASHP Conference for Leaders in Health-System Pharmacy. The conference was held October 17 and 18, 2005. The theme of the conference was "Balancing Competing Demands: Practical Strategies for Pharmacy Leaders."
The live program was written and presented by
Mick Hunt, Jr., senior Director of Pharmacy Services at Novation, L.L.C. in
Irving, Texas; Daniel Ashby, Director of Pharmacy at Johns Hopkins Hospital in
Baltimore, Maryland, and Bruce Scott, Chief Operating Officer at McKesson Medication Management in Brooklyn Park, Minnesota.
C.E. Credits: Not available for this program. Duration: 17 minutes
This podcast was produced by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.